{"schema_version":"secwatch.filing_event.v1","accession":"0001818331-22-000034","form_type":"8-K","ticker":"WGS","cik":"0001818331","company_name":"GeneDx Holdings Corp.","filed_at":"2022-03-14T23:59:59+00:00","discovered_at":"2026-05-14T18:04:08.407898+00:00","generated_at":"2026-06-26T23:20:51.299637+00:00","sec_items":["2.02","4.02","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.95,"calibrated_materiality_score":0.95,"confidence":"high","headline":"Sema4 announces non-reliance on previously issued financial statements and reports Q4 2021 results","bullets":["Non-reliance on previously issued financial statements for years ended Dec 31, 2020 and 2019 due to expense classification errors in cost of services and selling & marketing.","Identified adjustments in cost of services recognition for Q1-Q3 2021; restated financials to be included in 2021 10-K filed March 14, 2022.","Q4 2021 test volumes (ex-COVID) up 37% YoY; total revenue $57.8M, net loss $40.2M vs $125.7M loss in prior year.","Full year 2021 revenue $212.2M up from $179.3M; net loss $245.4M vs $241.3M.","Reiterates FY2022 revenue guidance $215-225M; expects to close GeneDx acquisition by end of Q2 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001818331-22-000034","json":"https://secwatch.observer/filing/0001818331-22-000034.json","markdown":"https://secwatch.observer/filing/0001818331-22-000034.md","text":"https://secwatch.observer/filing/0001818331-22-000034.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818331/000181833122000034/0001818331-22-000034-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818331/000181833122000034/smfr-20220310.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T23:20:51.299637+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}